Picture of Kaleido Biosciences logo

KLDO — Kaleido Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Kaleido Biosciences Says Alison Lawton To Step Down As Chief Executive Officer

June 16 (Reuters) - Kaleido Biosciences Inc  KLDO.O :
    * KALEIDO BIOSCIENCES ANNOUNCES CEO LEADERSHIP TRANSITION
    * KALEIDO BIOSCIENCES INC - ALISON LAWTON TO STEP DOWN AS
PRESIDENT AND CHIEF EXECUTIVE OFFICER TO ATTEND TO A FAMILY
HEALTH MATTER
    * KALEIDO BIOSCIENCES INC - ALISON LAWTON TO STEP DOWN AS
PRESIDENT AND CHIEF EXECUTIVE OFFICER
    * KALEIDO BIOSCIENCES - BOARD OF DIRECTORS HAS ESTABLISHED
AN
OFFICE OF CEO TO MANAGE COMPANY THROUGH TRANSITION
    * KALEIDO BIOSCIENCES - MIKE BONNEY, EXECUTIVE CHAIR, TO
LEAD
OFFICE OF CEO & ALISON LAWTON TO SERVE AS  SPECIAL ADVISOR

Source text for Eikon:  ID:nGNX6l24Qj 
Further company coverage:  KLDO.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Kaleido Biosciences

See all news